From CTV.ca:
A drug that curbs food cravings has been found to help users lose weight and raise good cholesterol. But researchers are cautioning that it is not a miracle drug.
A new Canadian study shows the drug rimonabant, known by the trade name Acomplia, will likely become a new contender in the war against obesity by helping patients lose dangerous abdominal fat and reduce the risk factors than can lead to heart disease and diabetes.
In a double-blind, placebo-controlled study of more than 1,000 overweight or obese patients, rimonabant, at its highest dose, produced a weight loss of an average 15 pounds (6.7 kg) over a year. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment